Lymphatic mapping and sentinel lymphadenectomy for melanoma

Seminars in Surgical Oncology

Volumn 14, Issue 4, 1998, Pages 283-290

  Kelley, Mark C ^a,b   Ollila, David W ^a   Morton, Donald L ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Intraoperative period; Lymph node excision; Lymph nodes pathology radionuclide imaging; Lymphatic metastasis; Melanoma; Neoplasm staging; Patient selection; Staining methods; Survival rate

Indexed keywords

DISULFINE BLUE; HUMAN SERUM ALBUMIN TC 99M; ISOSULFAN BLUE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

ALGORITHM; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; HUMAN; INTRADERMAL DRUG ADMINISTRATION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MELANOMA; MORBIDITY; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL TECHNIQUE;

HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; SKIN NEOPLASMS;

EID: 0031897122     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199806)14:4<283::AID-SSU4>3.0.CO;2-Z     Document Type: Review

References (33)

1. Essner R, Morton DL: Elective lymph node dissection. In LeJeune FJ, Chaudhuri PK, Das Gupta TK (eds): "Malignant melanoma." New York: McGraw-Hill; 1993, p. 205-214.
2. Balch CM, Soong SJ, Milton GW, et al.: A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA and New South Wales, Australia. Ann Surg 1982; 196:677-684.
3. Milton GW, Shaw HM, McCarthy WH, et al: Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1,319 patients. Br J Surg 1982; 69:108-111.
4. Veronesi U, Adamas J, Bandiera DC, et al.: Inefficacy of immediate node dissection in stase I melanoma of the limbs. N Engl J Med 1977; 297:627-630.
5. Veronesi U, Adamas J, Bandiera DC, et al.: Delayed regional node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982; 49:2420-2430.
6. Sim FH, Taylor WF, Ivins JC, et al : A prospective, randomized study of the efficacy of routine elective lymphadenectomy in the management of malignant melanoma. Preliminary results. Cancer 1978; 41:948-956.
7. Balch CM, Soong SJ, Bartolucci AA, et al.: Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996; 224:255-266.
8. Morton DL, Wen DR, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-399.
9. Morton DL, Wen DR, Cochran AJ: Management of early stage melanoma by intraoperarive lymphatic mapping and selective lymphadenectomy. Surg Oncol Clin North Am 1992; 1:247-259.
10. Reintgen D, Cruse CW, Wells K, et al.: The orderly progression of melanoma nodal metastases. Ann Surg 1994; 220:759-767.
11. Thompson JF, McCarthy WH, Bosch CM, et al.: Sentinel lymph node status as an indicator of the presence of melanoma in the regional lymph nodes. Melanoma Res 1995; 5:255-260.
12. Albertini JJ, Cruse CW, Rappaport D, et al.: Intraoperative radiolymphoscintigraphy improves sentinel node identification for patients with melanoma. Ann Surg 1996; 2:217-224.
13. Leong SP, Steinmetz I, Habib FA, et al.. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997; 132:666-673.
14. Lingam MK, Mackie RM, McKay AJ: Intraoperative identification of sentinel lymph node in patients with malignant melanoma. Br J Cancer 1997; 75:1505-1508.
15. Morton DL, Wen DR, Foshag LJ, et al.: Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanoma of the head and neck. J Clin Oncol 1993; 11:1751-1756.
16. Reintgen D, Balch CM, Kirkwood J, Ross M: Recent advances in the care of the patient with malignant melanoma [Review]. Ann Surg 1997; 225:1-14.
17. Gray HJ: Relation of the lymphatic vessels to the spread of cancer. Br J Surg 1939; 26:462-495.
18. Cox KR, Hare WS, Bruce PT. Lymphography in melanoma. Correlation of radiology with pathology. Cancer 1966; 19:637-647.
19. Wong JH, Cagle LA, Morton DL: Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg 1991; 214:637-641.
20. Bostick P, Essner R, Glass E, et al.: Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins [Abstract]. Society of Surgical Oncology 50th Annual Cancer Symposium: 1997 Mar 20-23; Chicago, IL. Abstracts book: 18.
21. Kirkwood JM, Strawderman MH, Ernstoff MS, et al.: Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996; 14:7-17
22. Balch CM: Finally, an effective adjuvant therapy for high-risk melanoma [editorial]. J Clin Oncol 1996; 14:1-3.
23. Glass EC, Essner R, Giuliano A, et al.: Comparative efficacy of three lymphoscintigraphic asents [Abstract]. Proc Soc Nucl Med 1995; 36:199.
24. Norman J, Cruse CW, Espinosa C, et al.: Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg 1991; 162:432-437.
25. Uren RF, Howman-Giles RB, Shaw HM, et al.: Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 1993; 34:1435-1440.
26. McCarthy WH, Thompson JF, Uren RF: Invited commentary on: DN Krag et al., Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995; 130:659-660.
27. Essner R, Foshag LJ, Morton DL. Intraoperative radiolymphoscintigraphy: a useful adjunct to intraoperative lymphatic mapping and selective lymphadenectomy in patients with clinical stage I melanoma [Abstract] Society of Surgical Oncology 47th Annual Cancer Symposium; 1994 Mar 17-20; Houston, TX. Abstracts book: 104.
28. Essner R, Glass EC, Morton DL: Preoperative and intraoperative lymphatic mapping employing technetium-99m human serum albumin for early stage melanoma [Abstract]. Proc Soc Nucl Med 1995; 5:223.
29. Krag DN, Meijer SJ, Weaver DL, et al.: Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995; 130:654-658.
30. Alex JC, Weaver DL, Fairbank JT, et al.: Gamma probe-guided lymph node localization in malignant melanoma. Surg Oncol 1993; 2:303-308.
31. Heller R, Becker J, Wassalle J, et al.: Detection of submicroscopic lymph node metastases in patients with malignant melanoma Arch Surg 1991; 126:1455-1460.
32. Wang X, Heller R, VanVoorhis N, et al.: Detection of submicroscopic metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994; 220:768-774.
33. Day CL Jr, Mihm MC Jr, Lew RA, et al.: Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51-3.99 mm). A conceptual model for tumor growth and mestastasis. Ann Surg 1982; 195:35-43.